BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30962285)

  • 21. Homology modeling and
    Elmezayen AD; Yelekçi K
    J Biomol Struct Dyn; 2021 Oct; 39(17):6396-6414. PubMed ID: 32715940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
    Ichikawa T; Li J; Meyer CJ; Janicki JS; Hannink M; Cui T
    PLoS One; 2009 Dec; 4(12):e8391. PubMed ID: 20027226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.
    Milde T; Oehme I; Korshunov A; Kopp-Schneider A; Remke M; Northcott P; Deubzer HE; Lodrini M; Taylor MD; von Deimling A; Pfister S; Witt O
    Clin Cancer Res; 2010 Jun; 16(12):3240-52. PubMed ID: 20413433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
    Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
    J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIPK2 overexpression relieves hypoxia/reoxygenation-induced apoptosis and oxidative damage of cardiomyocytes through enhancement of the Nrf2/ARE signaling pathway.
    Dang X; Zhang R; Peng Z; Qin Y; Sun J; Niu Z; Pei H
    Chem Biol Interact; 2020 Jan; 316():108922. PubMed ID: 31837296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
    Jin A; Li B; Li W; Xiao D
    Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of CTRP12 ameliorates hypoxia/re-oxygenation-induced cardiomyocyte injury by inhibiting apoptosis, oxidative stress, and inflammation via the enhancement of Nrf2 signaling.
    Jin AP; Zhang QR; Yang CL; Ye S; Cheng HJ; Zheng YY
    Hum Exp Toxicol; 2021 Dec; 40(12):2087-2098. PubMed ID: 34085554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
    Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
    Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
    J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
    Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes.
    Tsai CY; Wen SY; Cheng SY; Wang CH; Yang YC; Viswanadha VP; Huang CY; Kuo WW
    J Cell Biochem; 2017 Jul; 118(7):1659-1669. PubMed ID: 27859591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.
    Vega RB; Harrison BC; Meadows E; Roberts CR; Papst PJ; Olson EN; McKinsey TA
    Mol Cell Biol; 2004 Oct; 24(19):8374-85. PubMed ID: 15367659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites.
    Soriano FX; Chawla S; Skehel P; Hardingham GE
    J Neurochem; 2013 Jan; 124(1):26-35. PubMed ID: 23083128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells.
    Little GH; Bai Y; Williams T; Poizat C
    J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
    Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4.
    Backs J; Backs T; Bezprozvannaya S; McKinsey TA; Olson EN
    Mol Cell Biol; 2008 May; 28(10):3437-45. PubMed ID: 18332106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of FOXO6 alleviates hypoxia-induced apoptosis and oxidative stress in cardiomyocytes by enhancing Nrf2 activation via upregulation of SIRT6.
    Jin A; Zhang Q; Li S; Li B
    J Bioenerg Biomembr; 2020 Dec; 52(6):409-419. PubMed ID: 33123950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.
    Formisano L; Laudati G; Guida N; Mascolo L; Serani A; Cuomo O; Cantile M; Boscia F; Molinaro P; Anzilotti S; Pizzorusso V; Di Renzo G; Pignataro G; Annunziato L
    J Cereb Blood Flow Metab; 2020 Oct; 40(10):2081-2097. PubMed ID: 31696766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CRM1 nuclear export receptor controls pathological cardiac gene expression.
    Harrison BC; Roberts CR; Hood DB; Sweeney M; Gould JM; Bush EW; McKinsey TA
    Mol Cell Biol; 2004 Dec; 24(24):10636-49. PubMed ID: 15572669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1.
    Monovich L; Koch KA; Burgis R; Osimboni E; Mann T; Wall D; Gao J; Feng Y; Vega RB; Turner BA; Hood DB; Law A; Papst PJ; Koditek D; Chapo JA; Reid BG; Melvin LS; Pagratis NC; McKinsey TA
    Biochim Biophys Acta; 2009 May; 1789(5):422-31. PubMed ID: 19414071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.